- Home
- GOSS vs CPZ Comparison
GOSS vs CPZ Comparison
Compare GOSS & CPZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- CPZ
- Stock Information
- Founded
- GOSS 2015
- CPZ 2019
- Country
- GOSS United States
- CPZ United States
- Employees
- GOSS N/A
- CPZ N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- CPZ Trusts Except Educational Religious and Charitable
- Sector
- GOSS Health Care
- CPZ Finance
- Exchange
- GOSS Nasdaq
- CPZ Nasdaq
- Market Cap
- GOSS 347.8M
- CPZ 307.8M
- IPO Year
- GOSS 2019
- CPZ N/A
- Fundamental
- Price
- GOSS $1.84
- CPZ $16.20
- Analyst Decision
- GOSS Strong Buy
- CPZ
- Analyst Count
- GOSS 4
- CPZ 0
- Target Price
- GOSS $8.25
- CPZ N/A
- AVG Volume (30 Days)
- GOSS 3.6M
- CPZ 63.0K
- Earning Date
- GOSS 08-11-2025
- CPZ 01-01-0001
- Dividend Yield
- GOSS N/A
- CPZ 11.07%
- EPS Growth
- GOSS N/A
- CPZ N/A
- EPS
- GOSS N/A
- CPZ N/A
- Revenue
- GOSS $124,590,000.00
- CPZ N/A
- Revenue This Year
- GOSS N/A
- CPZ N/A
- Revenue Next Year
- GOSS $65.50
- CPZ N/A
- P/E Ratio
- GOSS N/A
- CPZ N/A
- Revenue Growth
- GOSS N/A
- CPZ N/A
- 52 Week Low
- GOSS $0.66
- CPZ $13.17
- 52 Week High
- GOSS $1.94
- CPZ $16.11
- Technical
- Relative Strength Index (RSI)
- GOSS 70.54
- CPZ 50.57
- Support Level
- GOSS $1.67
- CPZ $16.05
- Resistance Level
- GOSS $1.94
- CPZ $16.44
- Average True Range (ATR)
- GOSS 0.14
- CPZ 0.26
- MACD
- GOSS 0.04
- CPZ -0.02
- Stochastic Oscillator
- GOSS 86.81
- CPZ 36.36
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About CPZ Calamos Long/Short Equity & Dynamic Income Trust
Calamos L/S Equity & Dynamic Inc Trust is a trust company which seeks to provide current income and risk-managed capital appreciation. The company invests in securities across sectors such as Industrials, Healthcare, Financials, Consumer Discretionary and others.